Spinal cord regeneration: moving tentatively towards new perspectives
- PMID: 14757930
Spinal cord regeneration: moving tentatively towards new perspectives
Abstract
The failure of the adult human spinal cord to regenerate following injury is not absolute, but appears to be amenable to therapeutic manipulation. Recent work has shown that the provision of a growth permissive environment by the neutralization of inhibitory influences, or the grafting of fetal tissue, peripheral nerve, Schwann cells, or olfactory ensheathing cells can enhance regeneration in animal models of spinal cord injury. Stem cells are gaining ever-increasing favour as a treatment option for spinal cord injury. The potential of neural stem cells, embryonic stem cells, and bone marrow stromal cells is discussed. Additional treatment options such as pharmacological interventions, functional electrical stimulation and physiotherapy approaches are also explored. Basic science insights are used as a foundation for a discussion of a variety of clinical perspectives including repair of the chronically injured spinal cord, animal models of human spinal cord injuries and clinical trials. A more holistic approach towards spinal cord injury is suggested, one where a hierarchy of needs is recognised and quality of life is paramount. Finally, this review cautions against overly grandiose claims of an imminent miracle cure for human spinal cord injury.
Similar articles
-
Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration.Cell Transplant. 2002;11(6):593-613. Cell Transplant. 2002. PMID: 12428749 Review.
-
Transplantation of preconditioned Schwann cells following hemisection spinal cord injury.Spine (Phila Pa 1976). 2007 Apr 20;32(9):943-9. doi: 10.1097/01.brs.0000261408.61303.77. Spine (Phila Pa 1976). 2007. PMID: 17450067
-
Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries.Med Hypotheses. 2007;69(6):1234-7. doi: 10.1016/j.mehy.2007.04.011. Epub 2007 Jun 4. Med Hypotheses. 2007. PMID: 17548168
-
Stem cell transplantation and other novel techniques for promoting recovery from spinal cord injury.Transpl Immunol. 2004 Apr;12(3-4):343-58. doi: 10.1016/j.trim.2003.12.017. Transpl Immunol. 2004. PMID: 15157926 Review.
-
Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat.Acta Neurochir (Wien). 2005 Sep;147(9):985-92; discussion 992. doi: 10.1007/s00701-005-0538-y. Epub 2005 Jul 11. Acta Neurochir (Wien). 2005. PMID: 16010451
Cited by
-
Improvement of Contused Spinal Cord in Rats by Cholinergic-like Neuron Therapy.Iran Red Crescent Med J. 2013 Feb;15(2):127-35. doi: 10.5812/ircmj.7653. Epub 2013 Feb 5. Iran Red Crescent Med J. 2013. PMID: 23682324 Free PMC article.
-
Tailless-like (TLX) protein promotes neuronal differentiation of dermal multipotent stem cells and benefits spinal cord injury in rats.Cell Mol Neurobiol. 2011 Apr;31(3):479-87. doi: 10.1007/s10571-010-9642-5. Epub 2011 Jan 22. Cell Mol Neurobiol. 2011. PMID: 21258860 Free PMC article.
-
Repetitive Treatment with Diluted Bee Venom Attenuates the Induction of Below-Level Neuropathic Pain Behaviors in a Rat Spinal Cord Injury Model.Toxins (Basel). 2015 Jul 10;7(7):2571-85. doi: 10.3390/toxins7072571. Toxins (Basel). 2015. PMID: 26184310 Free PMC article.
-
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury.Invest Ophthalmol Vis Sci. 2012 Feb 23;53(2):986-94. doi: 10.1167/iovs.11-8833. Print 2012 Feb. Invest Ophthalmol Vis Sci. 2012. PMID: 22247454 Free PMC article.
-
Stem cells in amniotic fluid as new tools to study human genetic diseases.Stem Cell Rev. 2007 Dec;3(4):256-64. doi: 10.1007/s12015-007-9003-z. Stem Cell Rev. 2007. PMID: 17955390 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical